Connect with us

Cannabis

Democrats Decline To Include Cannabis Legalization In Party Platform

Avatar

Published

on

Delegates of the Democratic National Committee voted down a proposal to include the federal legalization of cannabis in the party’s 2020 platform on Monday. Platform committee delegate Dennis Obduskey of Colorado had introduced an amendment to include marijuana legalization in the platform, but the proposal was rejected by the committee with a vote of 105 to 60.

Several delegates spoke in favor of the legalization platform plank before the vote, including Stacey Walker, a county supervisor from Iowa, who referenced the words of civil rights activist and former Georgia congressman Rep. John Lewis in his comments.

“I’m imploring all of you to approach this with an open mind and heart. Do something big here,” Walker said to members of the platform committee via a video conference. “Take one small but meaningful step toward changing the course of history. If my Black life matters to you, you will consider this amendment. We want to get in good trouble today, and I urge you to do the right thing and support it.”

Draft Platform Supports Marijuana Decriminalization

Instead, the draft party platform, which is slated to be voted on by the close to 4,000 members of the full DNC prior to next month’s convention, calls for the decriminalization of cannabis.

This is the approach favored by likely Democratic presidential nominee Joe Biden.

“Democrats will decriminalize marijuana use and reschedule it through executive action on the federal level,” the draft reads. “We will support legalization of medical marijuana, and believe states should be able to make their own decisions about recreational use.”

The platform also called for reform of the nation’s broader drug policy, including a transition away from viewing drug abuse and addiction as a law enforcement issue.

“It is past time to end the failed “War on Drugs,” which has imprisoned millions of Americans— disproportionately people of color—and hasn’t been effective in reducing drug use. Democrats support policies that will reorient our public safety approach toward prevention, and away from over-policing—including by making evidence-based investments in jobs, housing, education, and the arts that will make our nation fairer, freer, and more prosperous,” reads the proposed platform.

“Substance use disorders are diseases, not crimes,” it continues. “Democrats believe no one should be in prison solely because they use drugs.”

In addition to supporting the right of states to legalize cannabis, the proposed platform calls for an end to federal enforcement of marijuana laws in those states that have done so and for the removal of federal marijuana convictions from defendants’ records.

“The Justice Department should not launch federal prosecutions of conduct that is legal at the state level. All past criminal convictions for cannabis use should be automatically expunged,” the party maintains in the draft. “And rather than involving the criminal justice system, Democrats support increased use of drug courts, harm reduction interventions, and treatment diversion programs for those struggling with substance use disorders.”

A Step Backward

Erik Altieri, the executive director of the National Organization for the Reform of Marijuana Laws (NORML), said in a statement that the Democratic Party platform’s cannabis reforms do not go far enough.

“It is impractical at best and disingenuous at worst for the Biden campaign to move ahead with these policy proposals,” Alteri said. “Rescheduling of marijuana under the Controlled Substances Act would continue to make the federal government the primary dictators of cannabis policy, and would do little if anything to address its criminal status under federal law.”

Colorado delegate Obduskey said the approved plank was a step backward from the party’s 2016 platform, which called for “providing a reasoned pathway for future legalization.”

Source: https://hightimes.com/news/democrats-decline-include-cannabis-legalization-party-platform/?utm_source=rss&utm_medium=rss&utm_campaign=democrats-decline-include-cannabis-legalization-party-platform

Cannabis

Report unveils largest donors to pro-legalization campaigns ahead of November 3 elections

Avatar

Published

on

A new report from Leafly released this week revealed the largest contributors to cannabis legalization campaigns in the United States ahead of the November 3 elections. 

According to campaign finance records, initiatives fighting to bring legal weed to a number of states this year have seen a fair amount of funding, the bulk of which came from cannabis companies and entrepreneurs. Other donors include unions, reforms advocates, private individuals and dispensaries. 

On the other hand, those financing anti-legalization efforts appear to be cash-strapped in comparison to donors contributing hundreds of thousands of dollars to support legal weed in Arizona, Montana, Mississippi, South Dakota and New Jersey, with significant contributions to the pro-psilocybin mushroom campaigns in Oregon and Washington D.C. as well.

Arizona

Leafly reports the legalization campaign in Arizona has raised nearly $3.5 million so far. Two new polls revealed the state appears to be likely to legalize cannabis this November, which means Arizonans will be able to legally purchase up to an ounce of weed soon.  

Cannabis companies were identified as the largest donors to Smart & Safe Arizona, the activists behind the initiative for legal pot in Arizona. These include Harvest, an Arizona-based medical marijuana company that has donated almost $1.5 million. Curaleaf and Cresco Labs have also donated several hundred thousand dollars to the campaign.  

Montana

Out of all the states that will vote on cannabis measures next month, Montana has raised the largest sum so far at over $7 million. Again, polls indicate the state is likely to legalize weed on November 3, when Montana residents will vote on a pair of measures to allow sales of marijuana to adults aged 21 and over. 

A PAC nonprofit organization from Washington D.C. dubbed The North Fund has been funneling millions into Montana’s legalization campaign. The money didn’t go unnoticed as anti-marijuana activists in Montana filed a complaint against the group recently, asking for The North Fund to disclose its donors. The North Fund donated $4,800,000 to New Approach Montana so far. 

New Jersey 

Another state which looks set to legalize marijuana on November 3 is New Jersey, where the top donor to the pro-legalization campaign has been The Scotts Company, a gardening and pest control company. Weedmaps donated $91,000 to the pro-legalization campaign, which enjoys support from New Jersey Governor Phil Murphy. 

A legal weed market in New Jersey could shape up to be one of the most lucrative in the country as neighboring states with large populations such as New York and Pennsylvania haven’t legalized cannabis. 

South Dakota

South Dakota will be the first state to vote on legalizing both medical and recreational sales in the same election. The state’s November ballot will feature both initiatives, which seem to be popular in Montana. 

The campaigns have raised over $1 million in donations so far, with national legalization groups contributing the largest sums. A restaurant owner from Sioux Falls ranks third on the list of campaign contributions with a $25,000 donation to the efforts.

Mississippi

Voters in Mississippi are heading to the polls to weigh in on medical marijuana legalization this November as well. The group behind the campaign has amassed over $1 million in donations so far.

Joel Bomgar, who serves in the Mississippi House of Representatives, donated over half a million. The Republican politician and tech entrepreneur was a key sponsor of the effort to legalize cannabis for medicinal use in Mississippi. 

Oregon and Washington D.C. 

Along with voting in the presidential election, voters in Oregon could legalize the therapeutic use of psilocybin found in psychedelic mushrooms. If voters approve the measure, Oregon will become the first U.S. state to allow the legal use of psilocybin. 

The New Approach PAC donated over $2.5 million to the effort, while other donors include entrepreneurs and a psychedelic therapy company. 

In Washington D.C., where people will cast their ballots on decriminalizing so-called magic mushrooms, the New Approach PAC donated $585,500 to the Decriminalize Nature D.C. campaign. 

Source: https://greencamp.com/report-unveils-largest-donors-to-pro-legalization-campaigns-ahead-of-november-3-elections/

Continue Reading

Cannabis

Will Legal Synthetic Cannabinoids Take Over Cannabis Industry?

Avatar

Published

on

We live in a world of synthetics. Most of our clothing is no longer cotton, but a mix of plastics. Much of our food is made of chemicals that can barely be pronounced. And now cannabis, our favorite smokable medicine and recreational pastime, might be replaced soon with legal synthetic cannabinoids.

It’s a world of synthetics

My mother used to work with a guy that had a great hookup for getting Coach bags. For anyone unfamiliar with the brand, Coach produces high quality leather bags, that come with a nice high price tag. My mother was buying tons of them, passing them on as gifts, and using a different one herself every day. They weren’t real of course, although I don’t remember how she found this out. They were knock-offs. Products that looked almost exactly the same, that felt almost exactly the same, but were actually made of entirely different materials, and overall of lesser quality. My mother was very unhappy when she realized what was going on, and never spoke again to her workmate who had bamboozled her, but buying synthetic products is pretty standard, and a lot of the time, most people never know that what they have isn’t the real thing.

Aren’t synthetic cannabinoids already a big thing?

Yes! Massive! In fact, if you read around the internet, you might get a little confused. Every time you see words like ‘spice’ and ‘k2’ being spoken about in reference to cannabis, its referring to synthetic cannabinoids. So, what’s the difference between these synthetic cannabinoids, and the legal synthetic cannabinoids that biotech industries are rushing to create and put on the market? Good question. While large biotech firms have the money and ability to make different concoctions, they aren’t technically producing anything terribly far off from the illegal version that people are constantly being warned against with terror stories of a few people dead over years of time. In the article cited it should be noted that most of the deaths weren’t even attributed to the synthetic cannabis, but rather a rat poison contaminant. Of course, somehow, those stories are all forgotten, or pushed aside, when the synthetics being spoken about come from companies that can sell their products above board, and have them taxed by the government. Funny how that works, right? While I suppose one could make the argument that its regulated vs unregulated, and that one is more dangerous than the other, the lack of relevant deaths from the unregulated version (no matter how much the very few that occur are publicized, let’s remember what it really means to have an epidemic of overdoses), and the standard story of putting down the one that doesn’t make the government tax dollars, while promoting the one that does – and which brings billions to large biotech companies – isn’t an unfamiliar story at all. So no, synthetic cannabis is far from new. I was smoking Mr. Nice Guy in Tel Aviv 10 years ago, and word on the street back then is that it was all synthetics. Now, with a massive 180º, the very thing being warned against constantly, is now the new thing being pushed by large biotech corporations.

CBG, or cannabigerol, a cannabinoid that makes up only about 1% of a cannabis plant by the time of harvest, and which has been associated – much like CBD – with pain management, as an anti-inflammatory, with neurodegenerative diseases, and with glaucoma. In fact, Willow Biosciences, has partnered with manufacturer Albany Molecular Research to create a large scale production of the cannabinoid – which also like CBD, has not been associated with psychoactive effects, making it a good addition to the medical cannabis family.

Willow is a Canadian company out of Calgary, but it’s already got a lot of competition. US based Biomedican Inc., of Fremont, California, is giving Willow a run for its money, claiming to already have a CBG strain that’s ready for mass production. Two other companies,  Demetrix and Amyris, are also looking to get specifically into the CBG game. In what is to me an incredibly and profoundly misconstrued statement, Headset, which apparently tracks cannabis trends, made the statement that cannabinoids on the market today are currently plant-derived for the most part, particularly with products like vape pens, but that synthetic versions should be coming soon. Now, this thought would have a lot more meaning if we weren’t constantly being told to stay away from ‘spice’ and ‘k2’, which are black market synthetic cannabinoids. In fact, the majority of vape pens being sold in a place like California, which has the biggest legal cannabis market, are knock-offs, and that means synthetic cannabinoids!! Whoever made the statement at Headset, which was picked up by Inquirer, must have only been speaking of the legal market, and the thing about cannabis, is that if you’re only looking at the legal market, you’re missing so much of what goes on. So much so that we’re having a conversation about legal synthetic cannabinoids as if they just came out, when the majority of us vaping pens, or smoking ‘fake weed’, have been using them for years…and generally without incident.

What are they making synthetics of?

Pretty much anything that can be isolated from the cannabis plant and serves some understood value. CBN, CBG, THC-A, THC-V, Delta-8 THC… This is probably a good time to remind about Marinol. While this whole discussion goes on about synthetics, its easy to forget that along with all the black market synthetics that are warned against, there’s also Marinol. Marinol, also known as Dronabinol, is an entirely synthetic cannabis medication which has been around since 1986 and is produced by several pharmaceutical companies at this point. So, not even pharmaceutically a new idea, it is quite possible that pharmaceutical versions of cannabis may not have, as of yet, made the dent in the industry that they were intended to.

patented, at least not in their natural form. However, changed, or synthetic versions, can be. So, while the cannabis game has been hard for pharmaceutical companies to control – creating a non-plant version gives our biotech and pharmaceutical compatriots a way to create a substance that can be patented.

What to expect

The general expectation is that the biotech and pharmaceutical industries will do everything they can to co-op the medical marijuana and general legal cannabis industries. Whether it will work or not is a different story. Sometimes pharmaceutical companies don’t have the pull they wish. If they did, everyone would be using Marinol, and Sativex already, and that’s not the case. The problem with cannabis, when it comes to big pharma, is that cannabis isn’t a pharmaceutical drug unless its made to be one. If the people are never interested in these new medical advents, then the old rules remain, and people keep smoking the plant. If big pharma can produce a product at the right price point, that’s accessible enough, and gets the job done, it could be a very different story. In this particular instance it’s an interesting battle for the market, and its hard to say how it will go. In the case of cannabis, the thing to remember is that we don’t technically need all this, and the more production that goes into it, the higher the cost, and the more need to find synthetic answers.

The takeaway

It looks like the legal medicinal cannabis market, (and possibly recreational one), will soon be flooded with legal synthetic cannabinoids. What will this really mean? Well, that’s up to all of you. If you want your plant to be a plant, then smoke your plant and nature wins. If you’re cool with the synthetic version, that go out and use it. The ability of the synthetic market to do well has mainly to do with the ability of biotech companies and governments to convince their people that synthetics are a better answer.

Thanks for stopping by CBDtesters.co, your hub for all things legal cannabis related. Check out our newsletter to keep up to date on all the latest news and products.

Source: https://cbdtesters.co/2020/10/16/will-legal-synthetic-cannabinoids-take-over-cannabis-industry/

Continue Reading

Cannabis

Majority of Montana voters support weed legalization ahead of November 3 vote

Avatar

Published

on

Voters in Montana appear to be set to legalize recreational cannabis in their state on November 3, the results of a new poll revealed this week. 

The state ballot will ask about legalizing recreational marijuana in Montana.

“Will you vote to support or oppose legalization?” the survey asked likely voters in Montana. Among them, 49% said they will vote to legalize marijuana, while 39% responded they would oppose the measure. Ten percent of voters said they are still undecided on the matter, but their votes could decide the fate of legal weed in Montana. 

Support for legal pot was higher among Democrats, as expected, with 70% of Democrat-voting respondents stating they would support legalization. On the other hand, only 27% of Montana Republicans said they are in favor of legal weed. Meanwhile, 59% of independent voters will vote to legalize marijuana. 

According to the poll, the initiative to legalize cannabis in the Treasure State is more popular among younger voters, with a majority of people between the ages of 18 and 59 stating they favor the measure. Most of the voters above the age of 60 said they intend to vote against legalization. 

The poll was conducted by Montana State University and gauged voter sentiment on a number of other elections that will take place on November 3, including the presidential race. As young voters interested in legalizing marijuana tend to vote for Democrats more often than for Republicans, having cannabis on the ballot could also affect the outcome of the Senate, House and presidential elections as well. 

Should Montana legalize pot, adults aged 21 and over will be able to legally purchase weed, while a 20% sales tax would be added to marijuana products. Furthermore, people with low-level marijuana sentences will be eligible for resentencing or the expungement of their records.

Earlier this week, a poll from New Jersey revealed the Garden State is also likely to legalize cannabis on November 3. Additionally, Arizona and South Dakota will vote on their respective legalization measures, while Mississippi voters will decide whether to allow medical marijuana in the state.

Meanwhile, Oregon will decide on a measure that would legalize psychedelic mushrooms for therapeutic use as voters in Washington D.C. weigh in on decriminalizing so-called magic mushrooms.  

Source: https://greencamp.com/majority-of-montana-voters-support-weed-legalization-ahead-of-november-3-vote/

Continue Reading
Fintech2 hours ago

Minimum Wage Workers Can Now Get Guaranteed Payday Loans No Matter What In Canada

Energy2 hours ago

Volvo Trucks Awarded $21.7M from U.S. EPA and South Coast AQMD to Deploy 70 Class 8 VNR Electric Zero-Emission Trucks

Energy2 hours ago

Trilliant Partners with 1NCE for a Cost-Effective Cellular Solution to Cover the Last Mile for IIoT

Energy2 hours ago

LyondellBasell Hosts Annual Global Care Day Supporting Food Security

Energy2 hours ago

Insider Buying Signals Gold Industry Momentum

Energy2 hours ago

In New Book, Veteran Journalist Shows How to End California’s Water Wars, Protect Habitats and Meet State’s Water Needs

Blockchain3 hours ago

How Does the Future Look for Cryptocurrencies in the Financial Market?

Cyber Security3 hours ago

Simple Steps To Protect Your Business Data Across Mobile Devices

Blockchain5 hours ago

How Blockchain Can Help Your Business Grow

Cyber Security6 hours ago

Quelques conseils pour améliorer la sécurité informatique afin de ne pas perdre des données personnelles

Aviation7 hours ago

Norwegian’s New Airbus A321LR Fleet – What To Expect

Ripple Price
Blockchain7 hours ago

Charted: Ripple (XRP) Technicals Suggest a Crucial Breakdown Below $0.24

Fintech7 hours ago

Insurtech Bolttech Expands Its Footprint to South Korea With LG U+

Aviation8 hours ago

Remember The Interjet-Aeromar Codeshare? Its Over

Blockchain8 hours ago

Savvy Traders Are Capitalizing on Two New Crypto Assets, Says Bitcoin Bull Tyler Swope – Here’s How

Aviation9 hours ago

One Of The World’s Busiest International Routes Is Less Than 300km Long

Aviation9 hours ago

Western Sydney cover up possible, hints top bureaucrat

Ethereum
Blockchain9 hours ago

TA: Ethereum Could Narrowly Avoid a Major Drop if it Closes Above $380

Aviation10 hours ago

A Look Inside Drake’s Crazy New Private Boeing 767 Jet

Aviation10 hours ago

Tasmania on track to open to NSW on 2 November

Aviation11 hours ago

Cathay Pacific Weighs Further Job And Pay Cuts

Aviation11 hours ago

What Is A Tail Strike And Why Can They Be Dangerous?

Bitcoin Price
Blockchain11 hours ago

TA: Bitcoin Hesitates Below $11,550, But Upside Break To $12K Seems Likely

Blockchain11 hours ago

Top DEXs Record 197% Average Monthly Trading Volume Increase As DeFi Hype Drives Growth

Blockchain12 hours ago

Bitstamp To Provide Crime Insurance for Crypto Asset Safety

Blockchain12 hours ago

Bitcoin Price Prediction: BTC/USD Struggles to Break $11,500 Resistance, May Set the Stage for Upside Momentum

check-out-thorchain-rune-shapeshift-ceo-erik-voorhees-says.jpg
Blockchain12 hours ago

“Check Out Thorchain (RUNE),” ShapeShift CEO Erik Voorhees Says

Aviation12 hours ago

Melbourne To Top Singapore Airlines’ Flight List In December – Here’s The Catch

Blockchain13 hours ago

Kraken Daily Market Report for October 18 2020

Aviation14 hours ago

United Airlines Moving Forward With Boeing 787 Polaris Retrofits

Chainlink LINK
Blockchain14 hours ago

Analyst: Chainlink Likely to Rally to $16.50 as It Approaches Key Level

Aviation14 hours ago

Victoria’s own website permitted ‘unauthorised’ Kiwi arrivals

Aviation15 hours ago

AirAsia X Cutting Indonesia Arm

options-trends-makes-it-hard-for-this-analyst-to-imagine-a-bitcoin-mega-pump.jpg
Blockchain15 hours ago

Options Trends Makes it Hard for This Analyst to Imagine a Bitcoin “Mega Pump”

Ecommerce15 hours ago

Embodee Announces Beta Availability of New Web Platform for 3D Fashion…

Ecommerce15 hours ago

Money Mailer Joins Capital One Spring Discount Platform for Small…

Blockchain16 hours ago

Outlier Detection with RNN Autoencoders

filecoin-fil-faces-a-miner-crisis-72-hours-into-launch-analyst-says.png
Blockchain16 hours ago

Filecoin (FIL) Faces a Miner Crisis 72 Hours Into Launch, Analyst Says

Aviation17 hours ago

Comment: Virgin bloodletting signals private-equity hijacking

Aviation17 hours ago

Fort Worth’s Drive-in Airshow Wraps a Successful Weekend

Trending